Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: WaferGen Shuffles Board; Spinomix Names Nahas as CEO

Premium

WaferGen Biosystems has shuffled and reduced the size of its board of directors to seven from nine following the firm's acquisition of IntegenX's next-generation sequencing library prep business.

Robert Schueren, IntegenX's CEO, will join WaferGen's board of directors. Prior to his role at IntegenX, Schueren was vice president and general manager of genomics at Agilent Technologies. The board also appointed William McKenzie as a director, effective Dec. 30, 2013. McKenzie most recently served as president and general manager of molecular diagnostics at PerkinElmer.

Scott Davidson and Joseph Pesce, representatives of Great Point Partners, stepped down from the board, as did Robert Coradini and Timothy Triche.


Swiss sample prep company Spinomix said this week that it has appointed Nasri Nahas as CEO.

Nahas was previously CEO of Geneva Bioinformatics, which he joined in 2011. Prior to that, Nahas held various scientific and business positions at biotech companies such as Genset and ValiGen.

Spinomix named Nahas as CEO in conjunction with an announcement that it had reached a milestone in its molecular diagnostics sample prep development plan, triggering an undisclosed second tranche payment from investor Debiopharm.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.